Brain Diseases
172
42
47
70
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
19 trials with published results (11%)
Research Maturity
70 completed trials (41% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.8%
10 terminated out of 172 trials
87.5%
+1.0% vs benchmark
6%
11 trials in Phase 3/4
27%
19 of 70 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 70 completed trials
Clinical Trials (172)
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
Gravity Stent-Retriever System For Reperfusion Of Large Vessel Occlusion Stroke Trial
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Bifocal Transcranial Alternating Current Stimulation Targeting the Frontoparietal Network in Stroke Patients
Video Call Assisted Assessment of Acute Stroke
Comprehensive Management of High-risk PopuLatIon for Stroke Based on Social Network
Effect of Hypoxic Conditioning on Cerebrovascular Health in the Elderly
Study to Evaluate the Efficacy and Safety of ATNC-MDD V1(TMS With Cognitive Training) in Mild Alzheimer's Dementia
Intra-arterial Thrombolysis for Acute Ischemic Stroke With Medium Vessel Occlusion
Stroke Cerebral Reorganization Pathways (SPECTRE)
Brain Tissue Specimen Collection
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of Inflammation
Effective Translation of Endovascular Thrombectomy Trials Into Real-world Practice in the Asia-Pacific
Pilot Study for PET/MR Imaging of Covid-19
Treating Depression on a Day-to-day Basis: Development of a Tool for Physicians Based on a Smartphone Application
Selective Activation of the Adrenomedullin Receptors in Migraine
Safety and Efficacy of SINOMED SR for Endovascular Treatment of Acute Ischemic Stroke
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Impact of COVID-19 Vaccines on Cerebrovascular Health